Occurrence of endemic plasmids causing β-lactam resistance in Enterobacteriaceae in Children's University Hospital in Munich

Folia Microbiologica

Volumn 49, Issue 4, 2004, Pages 457-464

  Benczeova S ^a   Adam, D ^b   Vrabelova M ^a   Michalkova Papajova D ^a   Kettner, M ^a  

^a Physics and Informatics   (Slovakia)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENTEROBACTERIACEAE; ESCHERICHIA COLI;

EID: 5444255212     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931609     Document Type: Article

References (26)

1. APPELGREN P., HELLSTRÖM I., WEITZBERG E., SÖDERLUND V., BINDSLEV V., RANSJÖ U.: Risk factors for nosocomial intensive care infection: a long-term prospective analysis. Acta Anaesthesiol.Scand. 45, 710-719 (2001).
2. ARAQUE M., NIEVES B., RUIZ O., DAGERT M.: Characterization of plasmids which mediate resistance to multiple antibiotics in Gram-negative bacteria of nosocomial origin. Enferm.Infect.Microbiol.Clin. 15, 299-305 (1997).
3. BRADFORD P.A.: Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology and detection of this important resistance threat. Clin.Microbiol.Rev. 14, 933-951 (2001).
4. BRADFORD P.A., CHERUBIN C.E., IDEMYOR V., RASMUSSEN B.A., BUSH K.: Multiply resistant K. pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime- hydrolyzing β-lactameses in a single isolate. Antimicrob.Agents Chemother. 38, 761-766 (1994).
5. BUJDÁKOVÁ H., HANZEN J., JANKOVIČOVÁ S., KLIMÁČKOVÁ J., MORAVČÍKOVÁ J., MILOŠOVIČ P., MICHÁLKOVÁ-PAPAJOVÁ D., KALLOVÁ J., KETTNER M.: Occurrence and transferability of β-lactam resistance in Enterobacteriaceae isolated in Children's University Hospital in Bratislava. Folia Microbiol. 46, 339-344 (2001).
6. FINNSTROM O., ISAKSSON B., HAEGGMAN S., BURMAN L.G.: Control of an outbreak of a highly β-lactam resistant Enterobacter cloacae strain in a neonatal special care unit. Acta Paediatr. 87, 1070-1074 (1998).
7. FORD-JONES E.L., MINDORFF C.M., LANGLEY J.M., ALLEN U., NAVAS L., PATRICK M.L., MILNER R., GODL R.: Epidemiologic study of 4684 hospital-acquired infections in pediatric patients. Pediatr.Infect.Dis.J. 8, 668-675 (1989).
8. FRANICZEK R., SOBIESZCZAŃSKA B., GRABOWSKI M., MOWSZET K., PYTRUS T.: Occurrence of extended-spectrum β-lactamases among Escherichia coli isolates from hospitalized and healthy children. Folia Microbiol. 48, 243-247 (2003).
9. HANDBERGER H., GARCIA-RODRIGUEZ J.A., GOBERNADO M., GOOSSENS H., NILSSON L.E., STRUELENS M.J.: Antibiotic susceptibility among aerobic Gram-negative bacilli in intensive care units in 5 European countries. J.Am.Med.Assoc. 6, 67-71 (1999).
10. JALALUDDIN S., DEVASTER J.M., SCHEEN R., GERARD M., BUTLLER J.P.: Molecular epidemiological study of nosocomial Enterobacter aerogenes isolates in a Belgian hospital. J.Clin.Microbiol. 36, 1846-1852 (1998).
11. JARLIER V., NICOLAS M., FOURNIER G., PHILIPPON A.: Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev.Infect.Dis. 10, 867-878 (1988).
12. JONES R.N.: Resistance patterns among nosocomial pathogens. Chest 119, 397S-404S (2001).
13. KETTNER M., MILOŠOVIČ P., HLETKOVÁ M., KALLOVÁ J.: Incidence and mechanism of aminoglycoside resistance in Pseudomonas aeruginosa serotype O11 isolates. Infection 23, 380-383 (1995).
14. LIPTÁKOVÁ A., SIEGFRIED L., PODRACKÁ L'., SABOL M., SEHNÁLKOVÁ H., BOGYIOVÁ E., ROSOCHA J., KMEŤOVÁ M., KERESTEŠOVÁ H., KOTULOVÁ D.: Detection of shiga toxins, intimin and enterohemolysin in Escherichia coli strains isolated from children in eastern Slovakia. Folia Microbiol. 47, 185-188 (2002).
15. MARCHANDIN H., CARRIERE C., SIROT D., JEAN-PIERRE H., DARBAS H.: TEM-24 produced by four different species of Enterobacteriaceae, including Providencia rettgeri, in a single patient. Antimicrob.Agents Chemother. 43, 2069-2073 (1999).
16. National Committee for Clinical Laboratory Standards (NCCLS): Method for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 5th ed. Approved Standard M7-A5. NCCLS, Philadelphia (USA) (2000).
17. O'CALLAGHAN C.H., MORRIS A., KIRBY S.M., SHINGLER A.H.: Novel method for detection of β-lactamase by using a chromogenic cephalosporin substrate. Antimicrob.Agents Chemother. 1, 283-288 (1972).
18. PEÑA C., PUJOL M., RICART A., ARDANUY C., AYATS J., LINARES J., GARRIGOSA F., ARIZA F., GUDIOL F.: Risk factors for fecal carriage of Klebsiella pneumoniae producing ESBL in the intensive care unit. J.Hosp.Infect. 35, 9-16 (1997).
19. Qiagen Plasmid Purification Handbook 09, 16-19 (2000).
20. RICE L.B.: Successful intervention for Gram-negative resistance to extended-spectrum β-lactam antiobiotics. Pharmacotherapy 19, 1205-1285 (1999).
21. RUPP M.E., FEY P.D.: Extended-spectrum β-lactamase-producing Enterobacteriaceae consideration for diagnosis, prevention and drug treatment. Drugs 63, 353-365 (2003).
22. SOBIESZCZAŃSKA B.M., OSER J.: Enteroaggregative and cell-detaching Escherichia coli strains among Polish children with and without diarrhea. Folia Microbiol. 48, 823-828 (2003).
23. STOVER B.H., SHULMAN S.T., BRATCHER D.F., BRADY M.T., LEVINE G.L., JARVIS W.R.: Nosocomial infections rates in US children's hospitals' neonatal and pediatric intensive care units. Am.J.Infect.Control 29, 152-157 (2001).
24. STRUELENS M.J.: The epidemiology of antimicrobial resistance in hospital-acquired infections: problems and possible solutions. Brit. Med.J. 317, 652-654 (1998).
25. TAKAHASHI S., NAGANO Y.: Rapid procedure for isolation of plasmid DNA and application to epidemiological analysis. J. Clin. Microbiol. 20, 608-613 (1984).
26. VRÁBELOVÁ M., KOLLÁROVÁ K., MICHÁLKOVÁ-PAPAJOVÁ D., HANZEN J., MILOŠEVIČ P., MAČIČKOVÁ T., KETTNER M.: Nosocomial plasmids responsible for multiresistance of bacterial isolates at different wards of the Children's University Hospital in Bratislava, Slovakia. J.Appl.Res. 4, 312-320 (2004).